Proprietary & Co-owned Portfolio (100+ assets)
Oncology, Neurology, Immunology, Cardiovascular & Metabolic Diseases
Discovery to PreclinicalActive
Key Facts
Indication
Oncology, Neurology, Immunology, Cardiovascular & Metabolic Diseases
Phase
Discovery to Preclinical
Status
Active
Company
About Evotec
Evotec is a technology-driven drug discovery and development powerhouse, offering a fully integrated R&D value chain from target identification to IND-enabling studies. Its business model combines standalone CRO services with integrated strategic partnerships and a co-owned portfolio of over 100 proprietary R&D assets. With a focus on scientific excellence and operational agility, Evotec aims to deliver unmatched speed and efficiency, ensuring better treatments reach patients sooner through its global team of over 4,800 experts.
View full company profile